It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Highlights
A self-propelled, biocatalytic buoyancy-driven metal–organic framework (MOF) nanobot is developed.
The anti-carcinoembryonic antigen antibody functionalized MOF nanobot demonstrates directional vertical motion to “find-and-fetch” cancer cells from mixed cell population.
The captured cells can be recovered with full metabolic potential.
Autonomously self-propelled nanoswimmers represent the next-generation nano-devices for bio- and environmental technology. However, current nanoswimmers generate limited energy output and can only move in short distances and duration, thus are struggling to be applied in practical challenges, such as living cell transportation. Here, we describe the construction of biodegradable metal–organic framework based nanobots with chemically driven buoyancy to achieve highly efficient, long-distance, directional vertical motion to “find-and-fetch” target cells. Nanobots surface-functionalized with antibodies against the cell surface marker carcinoembryonic antigen are exploited to impart the nanobots with specific cell targeting capacity to recognize and separate cancer cells. We demonstrate that the self-propelled motility of the nanobots can sufficiently transport the recognized cells autonomously, and the separated cells can be easily collected with a customized glass column, and finally regain their full metabolic potential after the separation. The utilization of nanobots with easy synthetic pathway shows considerable promise in cell recognition, separation, and enrichment.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 The University of New South Wales, School of Chemical Engineering, Australian Centre for NanoMedicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Northwest Minzu University, Medical College, Lanzhou, People’s Republic of China (GRID:grid.412264.7) (ISNI:0000 0001 0108 3408)
2 Second Affiliated Hospital of Zhejiang University School of Medicine, General Intensive Care Unit, Hangzhou, People’s Republic of China (GRID:grid.412465.0)
3 Northwest Minzu University, Medical College, Lanzhou, People’s Republic of China (GRID:grid.412264.7) (ISNI:0000 0001 0108 3408)
4 The University of New South Wales, School of Chemical Engineering, Australian Centre for NanoMedicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
5 Lanzhou University, School/Hospital of Stomatology, Lanzhou, People’s Republic of China (GRID:grid.32566.34) (ISNI:0000 0000 8571 0482)
6 Fudan University, Department of Chemistry, Shanghai Key Lab of Molecular Catalysis and Innovative Materials, Collaborative Innovation Center of Chemistry for Energy Materials, Shanghai, People’s Republic of China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
7 The University of New South Wales, Graduate School of Biomedical Engineering, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
8 University of California San Diego, Department of Nanoengineering, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
9 The University of New South Wales, School of Chemical Engineering, Australian Centre for NanoMedicine, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); The University of New South Wales, Graduate School of Biomedical Engineering, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)